In terms of mechanism, the decreased expression of kinase C zeta (PKC-ζ) in bone-derived breast cancer cells led to the upregulation of PHGDH, PSAT1 and PSPH, consequently promoted the utilization of glutamine through serine biosynthesis (70). This evidence concerns the gene PSPH and breast carcinoma.